October 6, 2006 | Park Hyatt Philadelphia
Wharton Finance Conference 2005 From Wall Street to Beijing

Wharton Finance Conference 2006


Keynote

Leon KalvariaLeon Kalvaria
Global Head of Consumer and Healthcare Investment Banking
Citigroup

Leon Kalvaria is the Global Head of Consumer and Healthcare Investment Banking and a member of Citigroup’s Global Investment Banking Operating Committee.

Mr. Kalvaria joined Schroders in 1996 as Global Head of the Consumer Investment Banking Group, and Citigroup in 2000 following the merger of the two companies. Prior to Schroders, Mr. Kalvaria served as Vice Chairman and a Director of Triarc Companies, a firm focused on investments in the consumer industry, and as Managing Director in the Mergers & Acquisitions Group at Credit Suisse First Boston.

Mr. Kalvaria’s extensive transaction experience includes advising Ford on its recent $15 billion sale of Hertz, advising the Santo Domingo Group on the sale of its $7.8 billion controlling interest in Bavaria (Colombia), advising Ambev on its $5.8 billion acquisition of Labatts and related transactions with Interbrew, advising Kellogg on its $4.7 billion acquisition of Keebler Foods, advising Molson in its $4.3 billion merger with Coors, advising Robert Mondavi on its $1.5 billion sale to Constellation Brands, advising Cadbury Schweppes on its $1.5 billion acquisition of Snapple Beverages, advising Fortune Brands on its $1.0 billion Reverse Morris Trust spinoff of Acco Brands and merger with GBC, advising Philip Morris and Kraft Foods and executing Kraft’s $8.7 billion IPO, advising Bristol-Myers Squibb on the sale of its Oncology Therapeutics Network division, advising UnitedHealth Group on its $7.4 billion acquisition of Pacificare Health Systems, advising Alaris Medical on its $2.0 billion sale to Cardinal Health, advising Quintiles Transnational on its $1.7 billion leveraged buyout, working with Wyeth on its $5 billion integrated convertible and debt offering, working with Amgen on its $5 billion convertible offering, working with Schering-Plough on its $3.8 billion convertible and debt offerings, and working with Teva Pharmaceuticals on its $2.75 billion concurrent convertible and senior notes offering.

Mr. Kalvaria received his BA from Princeton University’s Woodrow Wilson School of Public and International Affairs.

[ Back to Top ]